NASDAQ: STRO
Sutro Biopharma Inc Stock Ownership - Who owns Sutro Biopharma?

Insider buying vs selling

Have Sutro Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Edward C. AlbiniCFO AND SECRETARY2025-05-1515,995$0.88
$14.08kSell
Linda A. FitzpatrickCHIEF PEOPLE COMM. OFFICER2025-05-0113,538$1.07
$14.49kSell
Anne Elizabeth BorgmanCHIEF MEDICAL OFFICER2025-05-0124,709$1.07
$26.44kSell
Venkatesh SrinivasanCHIEF TECH OP OFFICER2025-05-01894$1.07
$956.58Sell
Venkatesh SrinivasanCHIEF TECH OP OFFICER2025-04-117,603$0.60
$4.56kSell
Linda A. FitzpatrickCHIEF PEOPLE COMM. OFFICER2025-03-053,594$1.36
$4.89kSell
William J. NewellCEO2025-03-056,708$1.36
$9.12kSell
Edward C. AlbiniCFO AND SECRETARY2025-03-053,594$1.36
$4.89kSell
Jane ChungPRESIDENT AND COO2025-03-042,334$1.42
$3.31kSell
William J. NewellCEO2025-03-0411,136$1.42
$15.81kSell

1 of 3

STRO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STRO insiders and whales buy or sell their stock.

STRO Shareholders

What type of owners hold Sutro Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Suvretta Capital Management LLC8.84%7,462,495$5.96MInstitution
Blackrock Inc7.35%6,204,784$4.96MInstitution
Kynam Capital Management LP6.44%5,441,447$4.35MInstitution
Ra Capital Management LP5.25%4,434,637$3.54MInstitution
Vanguard Group Inc5.20%4,395,244$3.51MInstitution
Acadian Asset Management LLC3.71%3,134,586$2.50MInstitution
Merck Co Inc3.22%2,723,509$2.18MInstitution
Merck Co Inc3.22%2,723,509$2.18MInsider
Vestal Point Capital LP3.08%2,600,000$2.08MInstitution
Eversept Partners LP2.71%2,292,261$1.83MInstitution

1 of 3

STRO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STRO73.02%18.21%Net SellingNet Selling
ARMP0.89%99.11%Net Selling
SNTI18.72%81.28%Net Buying
VANI3.32%96.68%Net BuyingNet Buying
IMRX12.50%38.58%Net Buying

Sutro Biopharma Stock Ownership FAQ

Who owns Sutro Biopharma?

Sutro Biopharma (NASDAQ: STRO) is owned by 73.02% institutional shareholders, 18.21% Sutro Biopharma insiders, and 8.77% retail investors. Merck Co Inc is the largest individual Sutro Biopharma shareholder, owning 2.72M shares representing 3.22% of the company. Merck Co Inc's Sutro Biopharma shares are currently valued at $2.18M.

If you're new to stock investing, here's how to buy Sutro Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.